4//SEC Filing
Besch Doug 4
Accession 0001628280-24-006021
CIK 0001448431other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 6:25 PM ET
Size
8.0 KB
Accession
0001628280-24-006021
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Besch Doug
Chief Product Officer
Transactions
- Award
Stock Option
2023-12-19+5,892→ 5,892 totalExercise: $12.73Exp: 2026-12-19→ Common Stock (5,892 underlying) - Award
Restricted Stock Units
2023-12-19+5,892→ 5,892 totalExp: 2026-12-19→ Common Stock (5,892 underlying)
Footnotes (3)
- [F1]The stock option vests in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.
- [F2]Restricted stock units convert into common stock on a one-for-one basis.
- [F3]The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001947731
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 6:25 PM ET
- Size
- 8.0 KB